Our research team consists of 6 faculty members, including 4 Professors, 2 associate Professors and over 30 graduate students (including 6 doctoral students and over 20 master students).

Our research team focus on epidemiological surveillance, risk warning, etiology, pathogenicity mechanism, antibiotic resistance, novel vaccines diagnosis, prevention and control technology of important animal and zoonotic bacterial infectious diseases. The research directions are as follow:

1. Research on the molecular epidemiology, antibiotic resistance, risk warning of important zoonotic and animal bacterial diseases: Conducting molecular epidemiological investigations, etiology and antibiotic resistance study to explore the genetic variation, virulence evolution and drug resistance transmission mechanisms of pathogenic bacteria, including Brucella, Escherichia coli, Salmonella, Mycoplasma, Riemerella anatipestifer, Clostridium perfringens and Mycobacterium tuberculosis. Determining the molecular basis, assessing risk and early warning for cross-species transmission of zoonotic and animal bacteria.

2. Research on the etiology, pathogenic mechanisms, immune mechanisms of important zoonotic and animal bacterial diseases: Focusing on the important zoonotic and animal bacterial pathogens, including Brucella, Escherichia coli, Salmonella, Mycoplasma, Riemerella anatipestifer, Clostridium perfringens, Mycobacterium, identifying bacterial novel virulence factors and determining their molecular pathogenic mechanisms and virulence regulation mechanisms. Exploring the pathogen-host interaction mechanisms and immune evasion mechanisms of zoonotic and animal bacteria.

3. Development and application of novel vaccines, diagnostic technologies, alternative control strategy for important zoonotic and animal bacterial diseases: Systematically screening and identifying novel antimicrobial targets via functional genomics, AI, reverse vaccinology. Developing novel vaccines, diagnostic technologies, adjuvants, AI monitoring technologies, bacteriophages, prebiotics, probiotics, and antimicrobial peptides to control important zoonotic and animal bacterial diseases.